Flow Cytometry in Oncology Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Global Flow Cytometry in Oncology Market is predicted to grow at a CAGR of 12% over the forecast period 2021-2027. 

Flow cytometry is an analytical tool used to measure and analyze several physical properties of cells or particles suspended in a fluid using a laser beam. This method helps to segment the cell type to determine the best treatment plan. It can also detect residual levels of disease after treatment. Factors such as increasing global incidence and prevalence of chronic diseases, increasing adoption of flow cytometry techniques in research and academia, and increasing initiatives in immunology and immuno-oncology research are expected to propel the growth of the global flow cytometry market. Additionally, the evolving pipeline for stem cell research and the adoption of recombinant DNA technology for antibody production provide significant revenue growth opportunities for players operating in this market.


Market Segments

By Technology

  • Cell-Based Flow Cytometry
  • Bead-Based Flow Cytometry

By Application

  • Research applications
  • Clinical Applications
  • Industrial Applications

Key Players

Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, bioAffinity Technologies, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cytek Biosciences, Cytognos, S.L., Danaher Corporation, Miltenyi Biotec B.V. & Co. KG, Laboratory Corporation of America Holdings, Luminex Corporation, NeoGenomics Laboratories, Inc., Sony Corporation, and Thermo Fisher Scientific Inc.

Scope of the Report

The research study analyzes the global Flow Cytometry in Oncology industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Flow Cytometry in Oncology Market Report

1. What was the Flow Cytometry in Oncology Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Flow Cytometry in Oncology Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Flow Cytometry in Oncology Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report will be delivered within 48-72 hours after payment confirmation